Mizuho Maintains Outperform on Ardent Health, Lowers Price Target to $12

Benzinga · 2d ago
Mizuho analyst Ann Hynes maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $20 to $12.